跳至主要内容
临床试验/NCT03333174
NCT03333174已完成不适用

Prematurity-Related Ventilatory Control (PRE-VENT): Role in Respiratory Outcomes Clinical Research Centers (CRC) - Specific Aim 3

University of Alabama at Birmingham2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2018年4月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
2
主要终点
Hypoxemic episode

研究概览

简要总结

To determine if servo-controlled oxygen environment is associated with reduction in (a) bradycardia events, (b) hypoxemic time, (c) bradycardia time, (d) apneic episodes

详细描述

This study will enroll the subset of infants enrolled in the main study (PreVENT Aim 1; 401-1000g at birth and/or 22w 0d-28w 6d; enrolled at <1 week postnatal age; eligible for full care and surviving beyond 24 hours, with informed consent; and with no major malformations) who are receiving oxygen supplementation at 32w and 36w postmenstrual age (PMA), and are not judged too unstable by the Attending neonatologist.

For infants on oxygen supplementation at 32w PMA, the investigators will use data from the 96 hours of intensive multiparametric physiologic monitoring at 32w PMA. For infants on oxygen supplementation at 36w PMA, we will use the 96 hours of intensive multiparametric physiologic monitoring at 36w PMA as well as data from the sleep study.

The first 24 hours of data collection will be the baseline data. Over the next 72 hours, the investigators will evaluate 3 interventions in a cross-over manner with the initial intervention (cannula or oxygen environment) randomly assigned: Intervention 1 (24-48h of data), Intervention 2 (48-72h of data) and Intervention 3 (72-96h of data).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Day 至 98 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Inborn infants weighing 401-1,000 grams on admission and/or 22w 0/7d to 28w 6/7d (<29 weeks) inclusive completed weeks of gestation
  • Infants eligible for full care and resuscitation as necessary, and surviving beyond 24 h of age
  • Enrollment in main study protocol (Aim 1 of PreVENT Apnea) at <1 week post-natal age
  • This study will enroll the subset of infants from Aim 1 who are receiving oxygen supplementation at 32w and 36w PMA, and are not judged too unstable by the Attending neonatologist
  • Informed consent from parent/guardian

排除标准

  • Refusal or withdrawal of consent Major congenital malformations (e.g., not including patent ductus arteriosus, small hernia)

结局指标

主要结局

Hypoxemic episode

时间窗: During 24 hour time periods with either intervention (nasal cannula vs. oxygen environment)

Hypoxemic episode defined as as oxygen saturation by pulse oximetry (SpO2) \<85% for \>10 seconds

次要结局

  • Apnea episodes(During 24 hour time periods with either intervention (nasal cannula vs. oxygen environment))
  • Bradycardic episode(During 24 hour time periods with either intervention (nasal cannula vs. oxygen environment))
  • Hypoxemic time defined as duration of time with SpO2 <85%(During 24 hour time periods with either intervention (nasal cannula vs. oxygen environment))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Namasivayam Ambalavanan

Principal Investigator

University of Alabama at Birmingham

研究点 (2)

Loading locations...

相似试验